Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter ...

A Potential Therapeutic Target for Steroid Resistant Asthma,” published in the December 2024 issue of Allergy and Immunology ...

Phase 1 healthy volunteer trial ongoing, with data expected in 2Q25Kymera plans to initiate a KT-621 Phase 1b trial in atopic ...

Gilead Sciences and LEO Pharma have entered a strategic collaboration to expedite the development and commercialisation of the latter’s small molecule oral signal transducer and activator of ...

This work sheds light on a new pathway controlling the functions of Th2 lymphocytes responsible for the deleterious immune response in the lungs of patients with type 2 asthma. They suggest that ...

Imperial researchers showed that subcutaneous immunotherapy suppressed Th2-T cell-driven allergic inflammation in the skin and nasal mucosa ... position paper on allergen Immunotherapy (2011), the ...

advancing it into Phase III clinical trials for a range of Th2-mediated inflammatory diseases. The diseases include chronic obstructive pulmonary disease (COPD), moderate-to-severe atopic dermatitis ...

Within the next year, KP-723 is expected to enter several Phase I trials in AD and may have applications in other Th2-mediated diseases, including asthma. 1 “To address the significant unmet need for ...

Stratifying patients according to phenotype therefore allows for better selection of available therapies. 13 In characterizing asthma as a T-helper 2 (Th2) immunologic disease, 2 major subtypes of ...

Figuring out how to find a doctor for your asthma can seem challenging at first—after all, you want to make sure that you’re getting the best treatment possible while also staying within your ...

During an asthma flare-up, sometimes called an asthma episode or an asthma attack, symptoms like coughing, wheezing, shortness of breath, and chest tightness get worse. People with asthma might go ...